Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

META-BRAIN · MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation

HORIZONStatus: SIGNED1 January 202431 December 2026EU funding €3,457,905Call HORIZON-EIC-2023-PATHFINDEROPEN-01

The pathological alterations of neurological function (e.g., stroke, trauma, neurodegeneration, epilepsy, neuropsychiatric diseases, chronic pain) are commonly associated with alterations in brain rhythms and activity patterns. There is an urgent clinical need for treatments that can precisely control and restore neural activity, taking advantage of state-of-the-art technological developments in a variety of fields including nanotechnology, nano- and microelectronics, novel materials, brain science, clinical neurology, and computational modelling. META-BRAIN (MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation) brings together seven expert partners in these fields with the aim of achieving precise spatiotemporal control of brain activity using magnetoelectric nanoarchitectures that can be polarized by non-invasive, remote magnetic fields. This novel principle of brain activity control will minimize the amplitude of the required magnetic fields, be wireless, and have enhanced spatial resolution from single neurons to cortical areas. We will develop a model-driven fabrication of the coils and monitor the effects on brain function with arrays of graphene microtransistors that uniquely allow full-band recording, integrating all elements in a closed loop. As an alternative to remote brain stimulation we will also use novel ultrasonic technologies. The META-BRAIN control paradigm will be systematically studied in pre-clinical systems from individual neurons to the full brain. All developments and experiments will be carried out in conjunction with theoretical models that will simulate, quantify, and predict optimal arrangements and patterns for the desired output. Translation to humans will be evaluated with our clinical partners, and a detailed dissemination and exploitation plan will be developed by two expert company partners, one of which has extensive expertise in the fabrication of brain interface devices with a worldwide distribution capability.

Consortium · 8 organisations

coordinator

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

ES · €953,420

participant

ZABALA INNOVATION CONSULTING SA

ES · €167,500

participant

KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA

CY · €427,500

participant

CONSIGLIO NAZIONALE DELLE RICERCHE

IT · €775,000

associatedPartner

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

CH

thirdParty

HOSPITAL CLINIC DE BARCELONA

ES

participant

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.

ES · €362,610

participant

G.TEC MEDICAL ENGINEERING GMBH

AT · €771,875

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.